Ozempic rules tightened – half of all diabetics may have to switch medication

Up to half of all those with type 2 diabetes in Denmark may have to change their medication, as the Danish Medicines Agency announces it will tighten the rules for subsidies on GLP-1 drugs.

Photo: Novo Nordisk

Up to half of all those with type 2 diabetes in Denmark may have to change their medication, as the Danish Medicines Agency announces it will tighten the rules for subsidies on certain drugs. The new rules apply to GLP-1 analogue medicines, which primarily consist of Novo Nordisk’s Ozempic.  A significant number of new diabetes […]


Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription

119

DKK/month.

(Billed once a month)

Give us a try

6 month subscription

99

DKK/month.

(Billed twice a year)

Save 120 DKK

Yearly subscription

79

DKK/month.

(Billed once a year)

Save 480 DKK

Save with a company subscription?